Regulatory
U.S. Health Secretary Robert F. Kennedy Jr. and officials from the United States — United States Department of Health and Human Services explored the possibility of banning certain Selective serotonin reuptake inhibitor (SSRI) antidepressants, including…
Impact: Selective serotonin reuptake inhibitor (SSRIs) are the class of antidepressants targeted by the United States — United States Department of Health and Human Services for potential restrictions and reduced use, which could significantly affect their market.
May 08, 2026 · 6 articles